Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Long-Term Deferred Tax (2016 - 2025)

Historic Long-Term Deferred Tax for Usana Health Sciences (USNA) over the last 15 years, with Q3 2025 value amounting to $24.2 million.

  • Usana Health Sciences' Long-Term Deferred Tax rose 4359.51% to $24.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.2 million, marking a year-over-year increase of 4359.51%. This contributed to the annual value of $19.6 million for FY2024, which is 4787.71% up from last year.
  • As of Q3 2025, Usana Health Sciences' Long-Term Deferred Tax stood at $24.2 million, which was up 4359.51% from $26.4 million recorded in Q2 2025.
  • In the past 5 years, Usana Health Sciences' Long-Term Deferred Tax ranged from a high of $26.4 million in Q2 2025 and a low of $4.5 million during Q2 2022
  • Its 5-year average for Long-Term Deferred Tax is $12.6 million, with a median of $12.2 million in 2022.
  • The largest annual percentage gain for Usana Health Sciences' Long-Term Deferred Tax in the last 5 years was 13822.51% (2022), contrasted with its biggest fall of 1204.49% (2022).
  • Usana Health Sciences' Long-Term Deferred Tax (Quarter) stood at $5.5 million in 2021, then skyrocketed by 79.3% to $9.8 million in 2022, then soared by 35.56% to $13.3 million in 2023, then soared by 47.88% to $19.6 million in 2024, then increased by 22.97% to $24.2 million in 2025.
  • Its last three reported values are $24.2 million in Q3 2025, $26.4 million for Q2 2025, and $18.8 million during Q1 2025.